Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Epirubicina")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 941

  • Page / 38
Export

Selection :

  • and

Extravasation of EpirubicinVANO-GALVAN, Sergio; JAEN, Pedro.The New England journal of medicine. 2009, Vol 360, Num 20, issn 0028-4793, p. 2117Article

Dexrazoxane: A promising antidote in the treatment of accidental extravasation of anthracyclinesJENSEN, Jesper Nested; LOCK-ANDERSEN, Jørgen; LANGER, Seppo W et al.Scandinavian journal of plastic and reconstructive surgery and hand surgery. 2003, Vol 37, Num 3, pp 174-175, issn 0284-4311, 2 p.Article

Factors affecting epirubicin pharmacokinetics and toxicity : Evidence against using body-surface area for dose calculationGURNEY, H. P; ACKLAND, S; GEBSKI, V et al.Journal of clinical oncology. 1998, Vol 16, Num 7, pp 2299-2304, issn 0732-183XArticle

Epirubicin Potentiates Recombinant Adeno-Associated Virus Type 2/5―Mediated TRAIL Expression in Fibroblast-like Synoviocytes and Augments the Antiarthritic Effects of rAA V2/5-TRAILJUAN SHI; ZHIJUAN DIAO; JIANSUO ZHOU et al.Arthritis and rheumatism. 2012, Vol 64, Num 5, pp 1345-1354, issn 0004-3591, 10 p.Article

Isolation and characterization of degradation impurities in epirubicin hydrochloride injectionKUMAR, Dinesh; RAJESH SINGH TOMAR; SANTOSH KUMAR DEOLIA et al.Journal of chromatography. B. 2008, Vol 869, Num 1-2, pp 45-53, issn 1570-0232, 9 p.Article

Maximum a posteriori Bayesian estimation of epirubicin clearance by limited samplingRALPH, Lorraine D; THOMSON, Alison H; DOBBS, Nicola A et al.British journal of clinical pharmacology. 2004, Vol 57, Num 6, pp 764-772, issn 0306-5251, 9 p.Article

What is the effect of adjusting epirubicin doses for body surface area?DOBBS, N. A; TWELVES, C. J.British journal of cancer. 1998, Vol 78, Num 5, pp 662-666, issn 0007-0920Article

Stability of intravesical epirubicin infusion: a sequential temperature studySEWELL, G. J; RIGBY-JONES, A. E; PRISTON, M. J et al.Journal of clinical pharmacy and therapeutics (Print). 2003, Vol 28, Num 5, pp 349-353, issn 0269-4727, 5 p.Article

Interaction of the anticancer drug epirubicin with DNAERDEM, Arzum; OZSOZ, Mehmet.Analytica chimica acta. 2001, Vol 437, Num 1, pp 107-114, issn 0003-2670Article

Application of preparative chromatography to the isolation of epirubicin from raw productYAN QI; JUNXIONG HUANG.Journal of liquid chromatography & related technologies. 2001, Vol 24, Num 18, pp 2837-2848, issn 1082-6076Article

A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinomaTURKINGTON, R. C; PURCELL, C; JAMES, C. R et al.Investigational new drugs. 2014, Vol 32, Num 2, pp 250-260, issn 0167-6997, 11 p.Article

Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endotheliumGAJALAKSHMI, Palanivel; KRISHNA PRIYA, Mani; PRADEEP, Thangaraj et al.Toxicology and applied pharmacology. 2013, Vol 269, Num 2, pp 121-131, issn 0041-008X, 11 p.Article

Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis : Urological OncologyHOUGHTON, Baerin B; CHALASANI, Venu; HAYNE, Dickon et al.BJU international (Papier). 2013, Vol 111, Num 6, pp 977-983, issn 1464-4096, 7 p.Article

Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC) ± bevacizumab ― Results of the randomised GeparQuinto study (GBG 44)HUOBER, Jens; FASCHING, Peter A; GERBER, Bernd et al.European journal of cancer (1990). 2013, Vol 49, Num 10, pp 2284-2293, issn 0959-8049, 10 p.Article

Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single-Blind, Randomized TrialMING SHI; LU, Li-Gong; ZHANG, Ya-Qi et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 1, pp 59-68, issn 0027-8874, 10 p.Article

A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)RENI, Michele; CEREDA, Stefano; BALZANO, Giampaolo et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 1, pp 115-123, issn 0344-5704, 9 p.Article

Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX TrialJOENSUU, Heikki; KELLOKUMPU-LEHTINEN, Pirkko-Liisa; VILLMAN, Kenneth et al.Journal of clinical oncology. 2012, Vol 30, Num 1, pp 11-18, issn 0732-183X, 8 p.Article

First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)—a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTGLINDEMANN, K; CHRISTENSEN, R. D; HIRTE, H et al.Annals of oncology. 2012, Vol 23, Num 10, pp 2613-2619, issn 0923-7534, 7 p.Article

7,3',4'-Trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen speciesLO, Yu-Li; WANJEN WANG; HO, Cheng-Ta et al.Toxicology (Amsterdam). 2012, Vol 302, Num 2-3, pp 221-232, issn 0300-483X, 12 p.Article

La Spectroscopie Raman (SR): un nouvel outil adapté au contrôle de qualité analytique des préparations injectables en milieu de soins. Comparaison de la SR aux techniques CLHP et UV/visible-IRTF appliquée à la classe des anthracyclines en cancérologie = The Raman Spectroscopy (RS): A new tool for the analytical quality control of injectable in health settings. Comparison of RS technique versus HPLC and UV/Vis-FTIR, applied to anthracyclines as anticancer drugsBOURGET, P; AMIN, A; MORICEAU, A et al.Pathologie et biologie. 2012, Vol 60, Num 6, pp 369-379, issn 0369-8114, 11 p.Article

Genome-wide association study of epirubicin-induced leukopenia in Japanese patientsSRINIVASAN, Yuvaraj; SASA, Mitsunori; HONDA, Junko et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 9, pp 552-558, issn 1744-6872, 7 p.Article

Multifactorial Approach to Predicting Resistance to AnthracyclinesDESMEDT, Christine; DI LEO, Angelo; MAEREVOET, Marie et al.Journal of clinical oncology. 2011, Vol 29, Num 12, pp 1578-1586, issn 0732-183X, 9 p.Article

Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomasWEIJING SUN; METZ, James M; GALLAGHER, Maryann et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 3, pp 621-627, issn 0344-5704, 7 p.Article

In vitro and in vivo study on the antioxidant activity of dexrazoxaneGALETTA, Fabio; FRANZONI, Ferdinando; CERVETTI, Giulia et al.Biomedicine & pharmacotherapy. 2010, Vol 64, Num 4, pp 259-263, issn 0753-3322, 5 p.Article

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the BladderSYLVESTER, Richard J; BRAUSI, Maurizio A; DE REIJKE, Theo M et al.European urology. 2010, Vol 57, Num 5, pp 766-773, issn 0302-2838, 8 p.Article

  • Page / 38